Quality of life (QOL) improvements for pomalidomide plus low-dose dexamethasone (POM + LoDEX) in relapsed and refractory multiple myeloma (RRMM) patients (pts) enrolled in MM-003.
Kevin W. Song
Disclosure not yet available
Meletios A. Dimopoulos
Disclosure not yet available
Katja C. Weisel
Disclosure not yet available
Philippe Moreau
Disclosure not yet available
Martha Lacy
Disclosure not yet available
Michel Delforge
Disclosure not yet available
Lionel Karlin
Disclosure not yet available
Hartmut Goldschmidt
Disclosure not yet available
Anne Banos
Disclosure not yet available
Albert Oriol Rocafiguera
Disclosure not yet available
Stacie Hudgens
Disclosure not yet available
Zhinuan Yu
Disclosure not yet available
Lars Sternas
Disclosure not yet available
Christian Jacques
Disclosure not yet available
Mohamed H. Zaki
Disclosure not yet available
Jesùs F. San-Miguel
Disclosure not yet available